Wallace Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $650K | Buy |
3,103
+279
| +10% | +$58.5K | 0.47% | 55 |
|
|
2025
Q1 | $502K | Sell |
2,824
-44
| -2% | -$7.82K | 0.35% | 84 |
|
|
2024
Q4 | $566K | Buy |
2,868
+149
| +5% | +$29.4K | 0.39% | 66 |
|
|
2024
Q3 | $466K | Hold |
2,719
| – | – | 0.34% | 78 |
|
|
2024
Q2 | $466K | Sell |
2,719
-361
| -12% | -$61.9K | 0.34% | 78 |
|
|
2024
Q1 | $477K | Sell |
3,080
-109
| -3% | -$16.9K | 0.36% | 77 |
|
|
2023
Q4 | $475K | Buy |
3,189
+166
| +5% | +$24.7K | 0.37% | 68 |
|
|
2023
Q3 | $407K | Buy |
3,023
+32
| +1% | +$4.31K | 0.29% | 93 |
|
|
2023
Q2 | $477K | Hold |
2,991
| – | – | 0.36% | 77 |
|
|
2023
Q1 | $477K | Buy |
2,991
+217
| +8% | +$34.6K | 0.36% | 77 |
|
|
2022
Q4 | $448K | Buy |
+2,774
| New | +$448K | 0.35% | 73 |
|